FSENX
Price
$82.90
Change
+$1.13 (+1.38%)
Updated
Jun 2 closing price
Net Assets
3.67B
HNRIX
Price
$39.34
Change
+$0.65 (+1.68%)
Updated
Jun 2 closing price
Net Assets
16.76M
Interact to see
Advertisement

FSENX vs HNRIX

Header iconFSENX vs HNRIX Comparison
Open Charts FSENX vs HNRIXBanner chart's image
FSENX vs HNRIX Comparison Chart in %
View a ticker or compare two or three
VS
FSENX vs. HNRIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSENX is a Buy and HNRIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSENX has more cash in the bank: 3.67B vs. HNRIX (16.8M). FSENX pays higher dividends than HNRIX: FSENX (1.63) vs HNRIX (0.62). FSENX was incepted earlier than HNRIX: FSENX (45 years) vs HNRIX (12 years). HNRIX (2.37) is less costly to investors than FSENX (0.65). HNRIX is a more actively managed with annual turnover of: 33.00 vs. FSENX (14.00). FSENX has a lower initial minimum investment than HNRIX: FSENX (0) vs HNRIX (250000). FSENX annual gain was more profitable for investors over the last year : 51.56 vs. HNRIX (41.22). FSENX return over 5 years is better than : 167.45 vs. HNRIX (155.12).
FSENXHNRIXFSENX / HNRIX
Total Expense Ratio0.652.2030%
Annual Report Gross Expense Ratio0.652.3727%
Fund Existence45 years12 years-
Gain YTD33.18425.576130%
Front LoadN/AN/A-
Min. Initial Investment0250000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.67B16.8M21,827%
Annual Yield % from dividends1.630.62262%
Returns for 1 year51.5641.22125%
Returns for 3 years67.1280.4483%
Returns for 5 years167.45155.12108%
Returns for 10 years135.28157.4486%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUGP1.070.05
+4.90%
SU Group Holdings Limited
BODI10.890.09
+0.83%
The Beachbody Company Inc
SNN29.36-0.12
-0.41%
Smith & Nephew plc
CLDX28.89-1.25
-4.15%
Celldex Therapeutics
WEAV6.03-0.45
-6.94%
Weave Communications